These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 25589420)

  • 1. [Cerebral MR imaging of malignant melanoma].
    Breckwoldt M; Bendszus M
    Radiologe; 2015 Feb; 55(2):113-9. PubMed ID: 25589420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracranial metastatic melanoma: correlation between MR imaging characteristics and melanin content.
    Isiklar I; Leeds NE; Fuller GN; Kumar AJ
    AJR Am J Roentgenol; 1995 Dec; 165(6):1503-12. PubMed ID: 7484597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolated cerebral susceptibility artefacts in patients with malignant melanoma: metastasis or not?
    Gramsch C; Göricke SL; Behrens F; Zimmer L; Schadendorf D; Krasny A; Forsting M; Schlamann MU
    Eur Radiol; 2013 Sep; 23(9):2622-7. PubMed ID: 23670820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebral metastatic malignant melanoma: CT and MR findings with pathological correlation.
    Dewulf P; Demaerel P; Wilms G; Delanote G; Defloor E; Casselman J; Baert AL
    J Belge Radiol; 1993 Oct; 76(5):318-9. PubMed ID: 8119873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computed tomography and magnetic resonance imaging of nonhemorrhagic, metastatic melanoma of the brain--case report.
    Uozumi A; Saegusa T; Ohsato K; Yamaura A
    Neurol Med Chir (Tokyo); 1990 Feb; 30(2):143-6. PubMed ID: 1695337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cerebral MRI in neurological asymptomatic patients with malignant melanoma].
    Schlamann M; Loquai C; Goericke S; Forsting M; Wanke I
    Rofo; 2008 Feb; 180(2):143-7. PubMed ID: 18098094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Susceptibility-weighted imaging in malignant melanoma brain metastasis.
    Schwarz D; Niederle T; Münch P; Hielscher T; Hassel JC; Schlemmer HP; Platten M; Winkler F; Wick W; Heiland S; Delorme S; Bendszus M; Bäumer P; Breckwoldt MO
    J Magn Reson Imaging; 2019 Oct; 50(4):1251-1259. PubMed ID: 30793419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis of cerebral metastases: double-dose delayed CT vs contrast-enhanced MR imaging.
    Davis PC; Hudgins PA; Peterman SB; Hoffman JC
    AJNR Am J Neuroradiol; 1991; 12(2):293-300. PubMed ID: 1902031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Visceral metastases from melanoma: findings on MR imaging.
    Premkumar A; Sanders L; Marincola F; Feuerstein I; Concepcion R; Schwartzentruber D
    AJR Am J Roentgenol; 1992 Feb; 158(2):293-8. PubMed ID: 1729784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The value of MRI in a case of cerebro-meningeal miliary carcinomatosis of melanotic origin].
    Marsot-Dupuch K; Michel G; Baudrimont M; Amarenco P
    Ann Radiol (Paris); 1989; 32(4):293-7. PubMed ID: 2817727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of Melanin Content and its Influence on Susceptibility Contrast in Melanoma Metastases.
    Straub S; Laun FB; Freitag MT; Kölsche C; von Deimling A; Denoix M; Bendszus M; Schlemmer HP; Ladd ME; Schneider TM
    Clin Neuroradiol; 2020 Sep; 30(3):607-614. PubMed ID: 31396654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of Susceptibility-Weighted Imaging (SWI) in the Detection of Brain Hemorrhagic Metastases from Breast Cancer and Melanoma.
    Franceschi AM; Moschos SJ; Anders CK; Glaubiger S; Collichio FA; Lee CB; Castillo M; Lee YZ
    J Comput Assist Tomogr; 2016; 40(5):803-5. PubMed ID: 27636126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MR imaging of hepatic metastasis in patients with malignant melanoma: evaluation of suspected lesions screened at contrast-enhanced CT.
    Sofue K; Tateishi U; Tsurusaki M; Arai Y; Yamazaki N; Sugimura K
    Eur J Radiol; 2012 Apr; 81(4):714-8. PubMed ID: 21353412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Whole-body MR imaging: evaluation of patients for metastases.
    Lauenstein TC; Goehde SC; Herborn CU; Goyen M; Oberhoff C; Debatin JF; Ruehm SG; Barkhausen J
    Radiology; 2004 Oct; 233(1):139-48. PubMed ID: 15317952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Brain metastases imaging].
    Delmaire C; Savatovsky J; Boulanger T; Dhermain F; Le Rhun E; Météllus P; Gerber S; Carsin-Nicole B; Petyt G
    Cancer Radiother; 2015 Feb; 19(1):16-9. PubMed ID: 25649387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A variety of appearances of malignant melanoma in the head: a review.
    Escott EJ
    Radiographics; 2001; 21(3):625-39. PubMed ID: 11353111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Miliary brain metastases from malignant melanoma.
    Rainov NG; Burkert W
    Zentralbl Neurochir; 1996; 57(1):20-4. PubMed ID: 8900895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain metastases--comparison of gadodiamide injection-enhanced MR imaging at standard and high dose, contrast-enhanced CT and non-contrast-enhanced MR imaging.
    Akeson P; Larsson EM; Kristoffersen DT; Jonsson E; Holtås S
    Acta Radiol; 1995 May; 36(3):300-6. PubMed ID: 7742127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamic contrast-enhanced MRI: differentiating melanoma and renal carcinoma metastases from high-grade astrocytomas and other metastases.
    Kremer S; Grand S; Berger F; Hoffmann D; Pasquier B; Rémy C; Benabid AL; Bas JF
    Neuroradiology; 2003 Jan; 45(1):44-9. PubMed ID: 12525954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracerebral malignant melanoma: high-field-strength MR imaging.
    Woodruff WW; Djang WT; McLendon RE; Heinz ER; Voorhees DR
    Radiology; 1987 Oct; 165(1):209-13. PubMed ID: 3628773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.